[Effects of Reducing FasL Expression on T Cell Apoptosis in Lung Cancer Cell Line H460 Via Sirna Technology].

Mingzhang Xiang,Yaoguang Jiang,Huichun Wang,Yidan Lin
DOI: https://doi.org/10.3779/j.issn.1009-3419.2007.01.02
2007-01-01
Abstract:BACKGROUND:Lung cancer cells can upregulate the expression of Fas ligand (FasL) and counterattack tumor-infiltration lymphocyte (TIL) expressing Fas via the FasL/Fas pathway, therefore escape from immunosurveillance and impair local anti-tumor immune capacity. The aim of this study is to investigate the effects of reducing FasL expression on T cell apoptosis in lung cancer cell line H460 via small interfering RNA (siRNA) technology.METHODS:In vitro chemically synthesized siRNA targeting FasL as well as constructed plasmid vector were transfected into H460 cells, wherein the interfering effect and alterations in T cell apoptosis were observed.RESULTS:Sequence-specific interfering effect was detected at RNA and protein levels by RT-PCR and Western blot in the H460 si group, and the reduction of FasL expression was capable of rescuing T cell apoptosis induced by lung cancer cells.CONCLUSIONS:FasL can be utilized as a new target in gene therapy of lung cancer.
What problem does this paper attempt to address?